Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

First published online October 26, 2006
Stem Cells Vol. 25 No. 2 February 2007, pp. 364 -370
doi:10.1634/stemcells.2006-0268; www.StemCells.com
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2006-0268v1
25/2/364    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, X.
Right arrow Articles by Li, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, X.
Right arrow Articles by Li, G.

TISSUE-SPECIFIC STEM CELLS

Chondrogenic Differentiation Alters the Immunosuppressive Property of Bone Marrow-Derived Mesenchymal Stem Cells, and the Effect Is Partially due to the Upregulated Expression of B7 Molecules

Xi Chena, Angela McClurgb, Guang-Qian Zhouc, Mervyn McCaiguea, Marilyn Ann Armstrongb, Gang Lia

Departments of aOrthopaedic Surgery,
bImmunology, and
cSurgery, Center for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, United Kingdom

Key Words. Mesenchymal stem cells • Immunogenicity • Chondrogenic differentiation • Dendritic cells

Correspondence: Gang Li, M.D., Ph.D., Department of Orthopaedic Surgery, School of Biomedical Sciences, Musgrave Park Hospital, Queen's University, Belfast BT9 7JB, United Kingdom. Telephone: 44-0-289090-2830; Fax: 44-0-289090-2825; e-mail: g.li{at}qub.ac.uk

Received May 2, 2006; accepted for publication October 20, 2006.
First published online in STEM CELLS EXPRESS   October 26, 2006.



To investigate the immunosuppressive properties of MSCs, in the present study we examined the immunogenicity of undifferentiated and trilineage-differentiated (chondrocytes, osteoblasts, and adipocytes) rat bone marrow-derived MSCs under xenogeneic conditions. After chondrogenic differentiation, rat bone marrow-derived MSCs stimulated human dendritic cells (hDCs) derived from peripheral blood monocytes, leading to eight- and fourfold higher lymphocyte proliferation and cytotoxicity than that of undifferentiated MSCs. The chondrogenic-differentiated MSCs were chemotactic to hDCs in Dunn chamber chemotaxis system and were rosetted by hDCs in rosette assays. Flow cytometry analysis revealed that chondrogenic-differentiated MSCs had promoted hDC maturation, causing higher CD83 expression in hDCs, whereas undifferentiated MSCs and osteogenic- and adipogenic-differentiated MSCs showed an inhibitory effect on hDC maturation. The costimulatory B7 molecules were upregulated only in the chondrogenic-differentiated MSCs. After blocking B7 molecules with specific monoclonal antibodies in the chondrogenic-differentiated MSCs, CD83 expression of cocultured hDCs was greatly reduced. In conclusion, chondrogenic differentiation may increase the immunogenicity of MSCs, leading to stimulation of dendritic cells. The upregulated expression of B7 molecules on the chondrogenic-differentiated MSCs may be partially responsible for this event.




This article has been cited by other articles:


Home page
 Stem CellsHome page
M. L. Weiss, C. Anderson, S. Medicetty, K. B. Seshareddy, R. J. Weiss, I. VanderWerff, D. Troyer, and K. R. McIntosh
Immune Properties of Human Umbilical Cord Wharton's Jelly-Derived Cells
Stem Cells, November 1, 2008; 26(11): 2865 - 2874.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2007 by AlphaMed Press.